9-Methyl-β-carboline up-regulates the appearance of differentiated dopaminergic neurones in primary mesencephalic culture

Neurochemistry International

Volumn 52, Issue 4-5, 2008, Pages 688-700

  Hamann, Juliane ^a   Wernicke, Catrin ^b   Lehmann, Jochen ^c   Reichmann, Heinz ^a   Rommelspacher, Hans ^b   Gille, Gabriele ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

9 Methyl carboline; Differentiation; Dopaminergic neurones; Neuroprotection; Transcription factors

Indexed keywords

9 METHYL BETA CARBOLINE; ADENOSINE TRIPHOSPHATE; CARBOLINE DERIVATIVE; CASPASE 3; LACTATE DEHYDROGENASE; NUCLEAR RECEPTOR RELATED FACTOR 1; PROTEIN EN1; PROTEIN EN2; PROTEIN PITX3; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT1 PROTEIN; WNT5A PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MARKER GENE; MESENCEPHALON; MOUSE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CONTENT; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIMETABOLITES; BROMODEOXYURIDINE; CARBOLINES; CASPASE 3; CELL COUNT; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; FEMALE; IMAGE PROCESSING, COMPUTER-ASSISTED; MESENCEPHALON; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; NERVE TISSUE PROTEINS; NEURONS; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TYROSINE 3-MONOOXYGENASE; UP-REGULATION;

MAMMALIA; NICOTIANA TABACUM; PARKINSONIA;

EID: 38349135366     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.08.018     Document Type: Article

References (60)

1. Alberi L., Sgado P., and Simon H.H. Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons. Development 131 (2004) 3229-3236
2. Albores R., Neafsey E.J., Drucker G., Fields J.Z., and Collins M.A. Mitochondrial respiratory inhibition by N-methylated beta-carboline derivatives structurally resembling N-methyl-4-phenylpyridine. Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 9368-9372
3. Baud V., and Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol. 11 (2001) 372-377
4. Bayer S.A., Wills K.V., Triarhou L.C., and Ghetti B. Time of neuron origin and gradients of neurogenesis in midbrain dopaminergic neurons in the mouse. Exp. Brain Res. 105 (1995) 191-199
5. Beier C.P., Wischhusen J., Gleichmann M., Gerhardt E., Pekanovic A., Krueger A., Taylor V., Suter U., Krammer P.H., Endres M., Weller M., and Schulz J.B. FasL (CD95L/APO-1L) resistance of neurons mediated by phosphatidylinositol 3-kinase-Akt/protein kinase B-dependent expression of lifeguard/neuronal membrane protein 35. J. Neurosci. 25 (2005) 6765-6774
6. Betarbet R., Turner R., Chockkan V., DeLong M.R., Allers K.A., Walters J., Levey A.I., and Greenamyre J.T. Dopaminergic neurons intrinsic to the primate striatum. J. Neurosci. 17 (1997) 6761-6768
7. Bonnet R., Pavlovic S., Lehmann J., and Rommelspacher H. The strong inhibition of triosephosphate isomerase by the natural beta-carbolines may explain their neurotoxic actions. Neuroscience 127 (2004) 443-453
8. Braestrup C., Schmiechen R., Neef G., Nielsen M., and Petersen E.N. Interaction of convulsive ligands with benzodiazepine receptors. Science 216 (1982) 1241-1243
9. Castelo-Branco G., Wagner J., Rodriguez F.J., Kele J., Sousa K., Rawal N., Pasolli H.A., Fuchs E., Kitajewski J., and Arenas E. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 12747-12752
10. Castro D.S., Hermanson E., Joseph B., Wallen A., Aarnisalo P., Heller A., and Perlmann T. Induction of cell cycle arrest and morphological differentiation by Nurr1 and retinoids in dopamine MN9D cells. J. Biol. Chem. 276 (2001) 43277-43284
11. Choi W.T., Youn Y.C., Han E.S., and Lee C.S. Protective effect of 1-methylated beta-carbolines against 3-morpholinosydnonimine-induced mitochondrial damage and cell viability loss in PC12 cells. Neurochem. Res. 29 (2004) 1807-1816
12. Chuang P.T., and McMahon A.P. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 397 (1999) 617-621
13. Collins M.A., and Neafsey E.J. β-Carboline analogues of MPP+ as environmental neurotoxins. In: Storch A., and Collins M.A. (Eds). Neurotoxic Factors in Parkinson's Disease and Related Disorders (2000), Kluwer Academic/Plenum Publishers, New York 115-129
14. Collins M.A., Neafsey E.J., Matsubara K., Cobuzzi Jr. R.J., and Rollema H. Indole-N-methylated beta-carbolinium ions as potential brain-bioactivated neurotoxins. Brain Res. 570 (1992) 154-160
15. Cossette M., Parent A., and Levesque D. Tyrosine hydroxylase-positive neurons intrinsic to the human striatum express the transcription factor Nurr1. Eur. J. Neurosci. 20 (2004) 2089-2095
16. Davis G.C., Williams A.C., Markey S.P., Ebert M.H., Caine E.D., Reichert C.M., and Kopin I.J. Chronic Parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1 (1979) 249-254
17. Fekkes D., and Bode W.T. Occurrence and partition of the beta-carboline norharman in rat organs. Life Sci. 52 (1993) 2045-2054
18. Gearhart D.A., Collins M.A., Lee J.M., and Neafsey E.J. Increased beta-carboline 9N-methyltransferase activity in the frontal cortex in Parkinson's disease. Neurobiol. Dis. 7 (2000) 201-211
19. Gearhart D.A., Neafsey E.J., and Collins M.A. Phenylethanolamine N-methyltransferase has beta-carboline 2N-methyltransferase activity: hypothetical relevance to Parkinson's disease. Neurochem. Int. 40 (2002) 611-620
20. Gille G., Radad K., Reichmann H., and Rausch W.D. Synergistic effect of alpha-dihydroergocryptine and l-dopa or dopamine on dopaminergic neurons in primary culture. J. Neural Transm. 113 (2006) 1107-1118 (Epub 2005 Oct 27)
21. Greiner B., Fahndrich C., Strauss S., and Rommelspacher H. Pharmacokinetics of tetrahydronorharmane (tetrahydro-beta-carboline) in rats. Naunyn Schmiedebergs Arch. Pharmacol. 322 (1983) 140-148
22. Hamann J., Rommelspacher H., Storch A., Reichmann H., and Gille G. Neurotoxic mechanisms of 2,9-dimethyl-beta-carbolinium ion in primary dopaminergic culture. J. Neurochem. 98 (2006) 1185-1199
23. Ho B.T., McIsaac W.M., Tansey L.W., and Walker K.E. Inhibitors of monoamine oxidase 3,9-substituted-beta-carbolines. J. Pharm. Sci. 58 (1969) 219-221
24. Ho B.T., and Walker K.E. 1,2,3,4-Tetrahydro-β-carboline. Org. Synth. Coll. 6 (1988) 965-966
25. Honecker H., and Rommelspacher H. Tetrahydronorharmane (tetrahydro-beta-carboline), a physiologically occurring compound of indole metabolism. Naunyn Schmiedebergs Arch. Pharmacol. 305 (1978) 135-141
26. Jankovic J., Chen S., and Le W.D. The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog. Neurobiol. 77 (2005) 128-138
27. Kuhn W., Muller T., Grosse H., and Rommelspacher H. Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients. J. Neural Transm. 103 (1996) 1435-1440
28. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
29. Lie D.C., Dziewczapolski G., Willhoite A.R., Kaspar B.K., Shults C.W., and Gage F.H. The adult substantia nigra contains progenitor cells with neurogenic potential. J. Neurosci. 22 (2002) 6639-6649
30. Matsubara K., Collins M.A., Akane A., Ikebuchi J., Neafsey E.J., Kagawa M., and Shiono H. Potential bioactivated neurotoxicants, N-methylated beta-carbolinium ions, are present in human brain. Brain Res. 610 (1993) 90-96
31. Matsubara K., Kobayashi S., Kobayashi Y., Yamashita K., Koide H., Hatta M., Iwamoto K., Tanaka O., and Kimura K. beta-Carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurology 45 (1995) 2240-2245
32. Maxwell S.L., Ho H.Y., Kuehner E., Zhao S., and Li M. Pitx3 regulates tyrosine hydroxylase expression in the substantia nigra and identifies a subgroup of mesencephalic dopaminergic progenitor neurons during mouse development. Dev. Biol. 282 (2005) 467-479
33. Nielsen M., and Braestrup C. Ethyl beta-carboline-3-carboxylate shows differential benzodiazepine receptor interaction. Nature 286 (1980) 606-607
34. Nunes I., Tovmasian L.T., Silva R.M., Burke R.E., and Goff S.P. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 4245-4250
35. Pavlovic S., Schulze G., Wernicke C., Bonnet R., Gille G., Badiali L., Kaminska A., Lorenc-Koci E., Ossowska K., and Rommelspacher H. 2,9-Dimethyl-beta-carbolinium, a neurotoxin occurring in human brain, is a potent inducer of apoptosis as 1-methyl-4-phenylpyridinium. Neuroscience 139 (2006) 1525-1537
36. Porritt M.J., Batchelor P.E., Hughes A.J., Kalnins R., Donnan G.A., and Howells D.W. New dopaminergic neurons in Parkinson's disease striatum. Lancet 356 (2000) 44-45
37. Prakash N., Brodski C., Naserke T., Puelles E., Gogoi R., Hall A., Panhuysen M., Echevarria D., Sussel L., Weisenhorn D.M., Martinez S., Arenas E., Simeone A., and Wurst W. A Wnt1-regulated genetic network controls the identity and fate of midbrain-dopaminergic progenitors in vivo. Development 133 (2006) 89-98
38. Prakash N., and Wurst W. Development of dopaminergic neurons in the mammalian brain. Cell Mol. Life Sci. 63 (2006) 187-206
39. Reiriz J., Espejo M., Ventura F., Ambrosio S., and Alberch J. Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J. Neurobiol. 38 (1999) 161-170
40. Rios I., Alvarez-Rodriguez R., Marti E., and Pons S. Bmp2 antagonizes sonic hedgehog-mediated proliferation of cerebellar granule neurones through Smad5 signalling. Development 131 (2004) 3159-3168
41. Rommelspacher H., Meier-Henco M., Smolka M., and Kloft C. The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. Eur. J. Pharmacol. 441 (2002) 115-125
42. Rommelspacher H., Nanz C., Borbe H.O., Fehske K.J., Muller W.E., and Wollert U. 1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding. Naunyn Schmiedebergs Arch. Pharmacol. 314 (1980) 97-100
43. Saucedo-Cardenas O., Quintana-Hau J.D., Le W.D., Smidt M.P., Cox J.J., De Mayo F., Burbach J.P., and Conneely O.M. Nurr1 is essential for the induction of the dopaminergic phenotype and the survival of ventral mesencephalic late dopaminergic precursor neurons. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 4013-4018
44. Shan X., Chi L., Bishop M., Luo C., Lien L., Zhang Z., and Liu R. Enhanced de novo neurogenesis and dopaminergic neurogenesis in the substantia nigra of 1-methyl-4-phyenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease-like mice. Stem Cells 24 (2006) 1280-1287
45. Simon H.H., Saueressig H., Wurst W., Goulding M.D., and O'Leary D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21 (2001) 3126-3134
46. Smidt M.P., van Schaick H.S., Lanctot C., Tremblay J.J., Cox J.J., van der Kleij A.A., Wolterink G., Drouin J., and Burbach J.P. A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13305-13310
47. Smits S.M., Ponnio T., Conneely O.M., Burbach J.P., and Smidt M.P. Involvement of Nurr1 in specifying the neurotransmitter identity of ventral midbrain dopaminergic neurons. Eur. J. Neurosci. 18 (2003) 1731-1738
48. Spijkerman R., van den E.R., van de M.D., Bongers I., and Fekkes D. The impact of smoking and drinking on plasma levels of norharman. Eur. Neuropsychopharmacol. 12 (2002) 61-71
49. Stephens D.N., Schneider H.H., Kehr W., Andrews J.S., Rettig K.J., Turski L., Schmiechen R., Turner J.D., Jensen L.H., and Petersen E.N. Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors. J. Pharmacol. Exp. Ther. 253 (1990) 334-343
50. Stull N.D., Jung J.W., and Iacovitti L. Induction of a dopaminergic phenotype in cultured striatal neurons by bone morphogenetic proteins. Brain Res. Dev. Brain Res. 130 (2001) 91-98
51. Sugimura T., Wakabayashi K., Ohgaki H., Takayama S., Nagao M., and Esumi H. Heterocyclic amines produced in cooked food: unavoidable xenobiotics. Princess Takamatsu Symp. 21 (1990) 279-288
52. Susilo R., and Rommelspacher H. Formation of a beta-carboline (1,2,3,4-tetrahydro-1-methyl-beta-carboline-1-carboxylic acid) following intracerebroventricular injection of tryptamine and pyruvic acid. Naunyn Schmiedebergs Arch. Pharmacol. 335 (1987) 70-76
53. Tse S.Y., Mak I.T., and Dickens B.F. Antioxidative properties of harmane and beta-carboline alkaloids. Biochem. Pharmacol. 42 (1991) 459-464
54. Vitalis T., Cases O., and Parnavelas J.G. Development of the dopaminergic neurons in the rodent brainstem. Exp. Neurol. 191 (2005) S104-S112
55. Volpicelli F., Perrone-Capano C., Da Pozzo P., Colucci-D'Amato L., and Di Porzio U. Modulation of nurr1 gene expression in mesencephalic dopaminergic neurones. J. Neurochem. 88 (2004) 1283-1294
56. Weinreb O., Mandel S., and Youdim M.B. cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. FASEB J. 17 (2003) 935-937
57. Wernicke C., Schott Y., Enzensperger Ch., Schulze G., Lehmann J., and Rommelspacher H. Cytotoxicity of β-carbolines in dopamine transporter expressing cells: structure-activity relationships. Biochem. Pharmacol. 74 (2007) 1065-1077
58. Zetterstrom R.H., Solomin L., Jansson L., Hoffer B.J., Olson L., and Perlmann T. Dopamine neuron agenesis in Nurr1-deficient mice. Science 276 (1997) 248-250
59. Zhao M., Momma S., Delfani K., Carlen M., Cassidy R.M., Johansson C.B., Brismar H., Shupliakov O., Frisen J., and Janson A.M. Evidence for neurogenesis in the adult mammalian substantia nigra. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 7925-7930
60. Zhou Q.Y., and Palmiter R.D. Dopamine-deficient mice are severely hypoactive, adipsic, and aphagic. Cell 83 (1995) 1197-1209